Research Calls II
-
Upgrades:
- Affirm (AFRM) upgraded to Neutral from Sell at Compass Point; tgt raised to $61
- Astera Labs (ALAB) upgraded to Outperform from Market Perform at Northland Capital; tgt $120
- Bancolombia S.A. (CIB) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $53
- CNH Industrial (CNH) upgraded to Outperform from Perform at Oppenheimer; tgt $16
- Victoria's Secret (VSCO) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $53
-
Downgrades:
- Eaton (ETN) downgraded to Hold from Buy at Melius; tgt $373
- Johnson Controls (JCI) downgraded to Hold from Buy at Melius; tgt $95
- Trane (TT) downgraded to Hold from Buy at Melius; tgt $398
- Vertiv (VRT) downgraded to Hold from Buy at Melius; tgt $125
-
Others:
- Armada Hoffler Properties (AHH) initiated with a Sector Perform at Scotiabank; tgt $11
- Cardiol Therapeutics (CRDL) initiated with a Buy at Rodman & Renshaw; tgt $7
- Eledon Pharmaceuticals (ELDN) initiated with a Buy at Guggenheim; tgt $9
- Indivior (INDV) initiated with a Buy at Rodman & Renshaw; tgt $16
- INmune Bio (INMB) initiated with a Buy at Rodman & Renshaw; tgt $23
- MindMed (MNMD) initiated with an Outperform at Evercore ISI; tgt $23
- Oklo Inc. (OKLO) initiated with a Buy at Craig Hallum; tgt $44
- PolyPid Ltd. (PYPD) initiated with a Buy at Rodman & Renshaw; tgt $13
- Rein Therapeutics (RNTX) initiated with a Buy at Rodman & Renshaw; tgt $8
- Talphera (TLPH) initiated with a Buy at Rodman & Renshaw; tgt $4